| P2093 | author name string | B Michael Ghadimi | |
| | Kia Homayounfar | |
| | Volker Ellenrieder | |
| | Otto Kollmar | |
| | Jan Erik Slotta | |
| P2860 | cites work | Biomarkers for hepatocellular carcinoma | Q21285158 |
| | Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma | Q24201669 |
| | Surgical resection versus liver transplant for patients with hepatocellular carcinoma | Q24201773 |
| | Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma | Q24235977 |
| | Cryotherapy for hepatocellular carcinoma | Q24240225 |
| | HOMOTRANSPLANTATION OF THE LIVER IN HUMANS | Q24658552 |
| | Liver transplantation: immunosuppression and oncology | Q26827252 |
| | Laparoscopic vs open approach to resection of hepatocellular carcinoma in patients with known cirrhosis: systematic review and meta-analysis | Q26864259 |
| | Systemic therapy of hepatocellular carcinoma: current status and future perspectives | Q26865844 |
| | Drug therapy for advanced-stage liver cancer | Q27004410 |
| | Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation | Q27014758 |
| | EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 |
| | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 |
| | Sorafenib in advanced hepatocellular carcinoma | Q27861075 |
| | Hepatocellular carcinoma in cirrhosis: incidence and risk factors | Q28290048 |
| | The global health burden of infection-associated cancers in the year 2002 | Q28290871 |
| | Hepatocellular carcinoma | Q29615765 |
| | Management of hepatocellular carcinoma | Q29616230 |
| | Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 |
| | Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial | Q29617955 |
| | Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma | Q29617957 |
| | Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis | Q29619508 |
| | Prognosis of hepatocellular carcinoma: the BCLC staging classification | Q29619984 |
| | Surgical technique: new advances for expanding indications and increasing safety in liver resection for HCC: the Eastern perspective | Q33387094 |
| | Total laparoscopic liver resection for hepatocellular carcinoma located in all segments of the liver | Q33387630 |
| | Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients | Q33407547 |
| | Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies | Q33414726 |
| | Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma | Q33629394 |
| | Value of radiofrequency ablation in the treatment of hepatocellular carcinoma | Q33661046 |
| | Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis | Q33748658 |
| | Chemoembolization for intermediate HCC: is there proof of survival benefit? | Q34050999 |
| | Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis | Q34203176 |
| | Recurrence after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis. | Q34383306 |
| | Magnetic resonance-guided laser-induced thermotherapy in patients with oligonodular hepatocellular carcinoma: long-term results over a 15-year period. | Q34407422 |
| | Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma | Q34510089 |
| | Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. | Q34515631 |
| | Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women | Q34520930 |
| | Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. | Q34581507 |
| | Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection | Q34618740 |
| | The end of cryotherapy for the treatment of nonresectable hepatic tumors? | Q81645342 |
| | Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma | Q82991747 |
| | Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization | Q83311969 |
| | Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis | Q84347694 |
| | Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q84424049 |
| | Efficacy of a hepatectomy and a tumor thrombectomy for hepatocellular carcinoma with tumor thrombus extending to the main portal vein | Q84511633 |
| | Surgical treatment of hepatocellular carcinoma | Q84590882 |
| | Three-dimensional conformal radiotherapy in combination with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma | Q85643473 |
| | Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT | Q87481895 |
| | Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma | Q87505166 |
| | The role of cryosurgery in the treatment of colorectal liver metastases: a matched-pair analysis of cryotherapy vs. liver resection | Q95400509 |
| | Safety of transarterial chemoembolization as bridging therapy in HCC patients with hyperbilirubinemia on the waiting list for liver transplantation: a centre experience | Q95580077 |
| | Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma | Q34627361 |
| | Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience | Q34630506 |
| | Radioembolization for hepatocellular carcinoma | Q34631431 |
| | Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies | Q34656782 |
| | GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis | Q34693220 |
| | Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations | Q34702094 |
| | Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. | Q34714683 |
| | Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization | Q34847211 |
| | Trans-arterial hepatic radioembolisation of yttrium-90 microspheres | Q34991390 |
| | Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis | Q34998414 |
| | Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma | Q35022635 |
| | Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review | Q35037545 |
| | Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma: a meta-analysis of 23 studies | Q35180185 |
| | Screening for hepatocellular carcinoma in cirrhosis | Q35594964 |
| | The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care | Q35833182 |
| | Ratio of remnant to total liver volume or remnant to body weight: which one is more predictive on donor outcomes? | Q36063364 |
| | Results of en bloc resection for hepatocellular carcinoma extending to adjacent organs | Q36113155 |
| | Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study | Q36309974 |
| | Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma | Q36376904 |
| | Hepatocellular carcinoma. A worldwide problem and the major risk factors | Q36401904 |
| | Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients | Q36429818 |
| | A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis | Q36557901 |
| | Epidemiology of hepatocellular carcinoma: consider the population | Q36930514 |
| | A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma | Q36934253 |
| | Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works | Q36980784 |
| | Treatment before liver transplantation for HCC. | Q37072516 |
| | Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular Carcinoma | Q37140658 |
| | Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation | Q37241865 |
| | Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size | Q37296885 |
| | Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States | Q37322087 |
| | Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis | Q37341959 |
| | Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics | Q37355835 |
| | Sorafenib for the treatment of unresectable hepatocellular carcinoma | Q37368694 |
| | Transcatheter arterial chemoembolization and radiation therapy for treatment-naïve patients with locally advanced hepatocellular carcinoma | Q37687300 |
| | Modified RECIST (mRECIST) assessment for hepatocellular carcinoma | Q37696396 |
| | Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review | Q37770120 |
| | Current role of selective internal irradiation with yttrium-90 microspheres in the management of hepatocellular carcinoma: a systematic review. | Q37796108 |
| | Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma | Q37863049 |
| | Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: a meta-analysis | Q37946476 |
| | Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia | Q37972814 |
| | How much remnant is enough in liver resection? | Q37996301 |
| | Is resection equivalent to transplantation for early cirrhotic patients with hepatocellular carcinoma? A meta-analysis | Q38029966 |
| | Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis | Q38033646 |
| | The learning curve in laparoscopic major liver resection | Q38052028 |
| | Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study. | Q38062681 |
| | Laparoscopic major hepatectomy: a systematic literature review and comparison of 3 techniques | Q38069446 |
| | Yttrium-90 radioembolization for hepatocellular carcinoma: what we know and what we need to know | Q38083431 |
| | Robotic-assisted hepatic resection: a systematic review. | Q38113154 |
| | Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients | Q38144873 |
| | Anatomic versus non-anatomic liver resection for hepatocellular carcinoma: a systematic review | Q38203523 |
| | Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses | Q38206111 |
| | Oxaliplatin-based chemotherapy: a new option in advanced hepatocellular carcinoma. a systematic review and pooled analysis | Q38214175 |
| | Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations | Q38224434 |
| | Orthotopic homotransplantation of the human liver | Q38540105 |
| | Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience | Q38855543 |
| | In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? | Q38984450 |
| | Radiosensitization by combining an aurora kinase inhibitor with radiotherapy in hepatocellular carcinoma through cell cycle interruption | Q39038781 |
| | Etiologic influence on chromosomal aberrations in European hepatocellular carcinoma identified by CGH. | Q39412966 |
| | Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells | Q40177724 |
| | Transarterial chemoembolisation in hepatocellular carcinoma | Q40257307 |
| | Laparoscopic resection for hepatocellular carcinoma: eastern and western experiences | Q41552471 |
| | Laparoscopic resection for hepatocellular carcinoma: comparison between Middle Eastern and Western experience | Q41552525 |
| | Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials | Q41849760 |
| | A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients | Q42203185 |
| | Microwave ablation for hepatic malignancies: a multiinstitutional analysis. | Q42621756 |
| | The learning curve in laparoscopic liver resection: improved feasibility and reproducibility. | Q42635552 |
| | Laparoscopic major hepatectomy: an evolution in standard of care. | Q42635766 |
| | Robot-assisted laparoscopic liver resection for hepatocellular carcinoma: short-term outcome. | Q43446518 |
| | Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants | Q43571831 |
| | Cryotherapy for cirrhosis-based hepatocellular carcinoma: a single center experience from 1595 treated cases | Q43799588 |
| | "State of the art" in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers | Q44127578 |
| | Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis | Q44149115 |
| | Liver resection improves the survival of patients with multiple hepatocellular carcinomas | Q44264077 |
| | Ultrasound-guided ablative therapy for hepatic malignancies : a comparison of the therapeutic effects of microwave and radiofrequency ablation | Q44269513 |
| | Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis | Q44450344 |
| | Expanded criteria for hepatocellular carcinoma after liver transplantation: a 20-year evolution | Q44814055 |
| | Ultrasound-guided percutaneous cryotherapy of hepatocellular carcinoma. | Q45030295 |
| | EASL and mRECIST responses are independent predictors of survival in hepatocellular carcinoma patients treated with cryoablation | Q45419071 |
| | Percutaneous microwave ablation of hepatic tumors: prospective evaluation of postablation syndrome and postprocedural pain. | Q45684056 |
| | Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma. | Q45947114 |
| | Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients. | Q46024307 |
| | Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival | Q46743120 |
| | The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients | Q47181945 |
| | Remnant liver volume to body weight ratio > or =0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver | Q47308498 |
| | Quality of life after surgical resection compared with radiofrequency ablation for small hepatocellular carcinomas | Q48074911 |
| | Laparoscopic liver resection: lessons learnt after 100 cases. | Q50671188 |
| | Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. | Q51816928 |
| | Is portal hypertension a contraindication to hepatic resection? | Q53061460 |
| | Pure laparoscopic right hepatectomy by anterior approach with hanging maneuver for large intrahepatic cholangiocarcinoma. | Q53100686 |
| | Strategy of treatment for hepatocellular carcinomas with vascular infiltration in patients undergoing hepatectomy. | Q53337276 |
| | Role of intercostal trocars on laparoscopic liver resection for tumors in segments 7 and 8. | Q53547950 |
| | Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis | Q56777584 |
| | Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis | Q56970979 |
| | Efficacy of transarterial chemoembolization prior to liver transplantation for hepatocellular carcinoma as found in pathology | Q57205229 |
| | National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers | Q57941127 |
| | FOLFOX-4 vs. doxorubicin for hepatocellular carcinoma: Could a negative result be accepted as positive? | Q58021056 |
| | Liver transplantation in patients with hepatocellular carcinoma across Milan criteria | Q58283868 |
| | Surgical Resection Is Better than Transarterial Chemoembolization for Hepatocellular Carcinoma Beyond Milan Criteria Independent of Performance Status | Q58576483 |
| | Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma | Q59647309 |
| | Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma | Q60442452 |
| | A new method of segmental orthotopic liver transplantation in children. | Q64943643 |
| | [Transplantation of a donor liver to 2 recipients (splitting transplantation)--a new method in the further development of segmental liver transplantation] | Q68140836 |
| | Liver transplantation from live donors | Q69373252 |
| | Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma | Q72730223 |
| | Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study | Q78873230 |
| | Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma | Q79854314 |
| | Improving resectability of hepatic colorectal metastases: expert consensus statement | Q80218589 |
| | Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments | Q81631203 |
| P433 | issue | 9 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 1168-1183 | |
| P577 | publication date | 2015-05-01 | |
| P1433 | published in | World Journal of Hepatology | Q27723328 |
| P1476 | title | Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives | |
| P478 | volume | 7 | |